Vulnerability · Published Jun 18, 2026 · Assigned by icscert
CVE-2026-52866Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Missing Authorization
Medium 6.5
In plain English
A medium-severity missing authorization in Blood Glucose Monitoring System (Model No. APG-01 BT) from Apollo Pharmacy. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 0.3% (higher than 28% of all known vulnerabilities).
Severity (CVSS 3.1)6.5Medium
Exploit odds (30 days)0.3%top 71.5% of all CVEs
Exploited in the wildNo reportsCISA SSVC: none
Attack toolingNoneno public tooling known
Official description
An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection.
Affected products (as reported)
| Vendor | Product | Versions |
|---|---|---|
| Apollo Pharmacy | Blood Glucose Monitoring System (Model No. APG-01 BT) | 0x0110_v1.1.0 |
Weakness: CWE-862 · Vector: CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H